Top Markets
Coin of the day
Hemostemix Inc. Hemostemix Inc.

Hemostemix Inc.

HEM
Kedudukan dalam Saham #32158
Hemostemix Inc., a clinical stage biotechnology company, develops,... Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, which is in Phase II clinical trial for the treatment of vascular diseases, such as peripheral arterial disease, angina pectoris, and ischemia, as well as heart failure, ischemic and dilated cardiomyopathy, chronic limb threatening ischemia, vascular dementia, and brain function. The company also develops NCP-01, which is preclinical trial to evaluate effect on neuropathic pain and motor function recovery. Hemostemix Inc. is headquartered in Calgary, Canada.
Harga Saham
$0.05504527
Disegerakkan terakhir: 2026-08-17
Modal Pasaran
$10.89M
Perubahan (1 hari)
15.38%
Perubahan (1 tahun)
-10.64%
Negara
CA
Perdagangan Hemostemix Inc. (HEM)

Kategori

Nisbah P/S bagi Hemostemix Inc. (HEM)
Nisbah P/S pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini Hemostemix Inc., nisbah P/S semasa (TTM) ialah 0. Pada akhir 2026, nisbah P/S syarikat ialah 0.
Sejarah nisbah P/S untuk Hemostemix Inc. dari 2026 hingga 2026
Nisbah P/S pada akhir setiap tahun
Tahun Nisbah P/S Ubah
Tidak cukup data untuk tarikh yang disediakan.
Nisbah P/S untuk syarikat atau pesaing yang serupa
Syarikat Nisbah P/S Perbezaan Nisbah P/S Negara
10.17 -
US
10.13 -
NL
2.95 -
AU
- -
CH
- -
KR